4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Fangzhou Inc. (6086) operates in the Pharmaceutical Retailers industry and is headquartered in Guangzhou, China with about 494 employees. Its market capitalization is roughly CNY 998 million. In the fiscal year ended 2025-12-31, 6086 reported CNY 3.5B in revenue and CNY 12M in net income.
Fangzhou Inc. provides online chronic disease management services in China. It operates through four segments: Online Retail Pharmacy Services; Comprehensive Medical Services; Wholesale; and Customized Content and Marketing Solutions.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 3.5B | CNY 2.7B | CNY 2.4B | CNY 2.2B | — |
| Gross Profit | CNY 559M | CNY 516M | CNY 487M | CNY 381M | — |
| Operating Income (EBIT) | CNY 12M | (CNY 749M) | (CNY 27M) | (CNY 127M) | — |
| Net Income | CNY 12M | (CNY 855M) | (CNY 197M) | (CNY 383M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 814M | CNY 664M | CNY 521M | CNY 519M | — |
| Total Liabilities | CNY 660M | CNY 532M | CNY 2.4B | CNY 2.2B | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 6086 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms